| MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia R Garzon, F Pichiorri, T Palumbo, M Visentini, R Aqeilan, A Cimmino, ... Oncogene 26 (28), 4148-4157, 2007 | 472 | 2007 |
| Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells M Rakhmanov, B Keller, S Gutenberger, C Foerster, M Hoenig, ... Proceedings of the National Academy of Sciences 106 (32), 13451-13456, 2009 | 383 | 2009 |
| Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study I Quinti, A Soresina, A Guerra, R Rondelli, G Spadaro, C Agostini, C Milito, ... Journal of clinical immunology 31, 315-322, 2011 | 300 | 2011 |
| Prospective study of guideline‐tailored therapy with direct‐acting antivirals for hepatitis C virus‐associated mixed cryoglobulinemia L Gragnani, M Visentini, E Fognani, T Urraro, A De Santis, L Petraccia, ... Hepatology 64 (5), 1473-1482, 2016 | 223 | 2016 |
| Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection L Arcaini, C Besson, M Frigeni, H Fontaine, M Goldaniga, M Casato, ... Blood, The Journal of the American Society of Hematology 128 (21), 2527-2532, 2016 | 184 | 2016 |
| Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups C Ferri, F Ursini, L Gragnani, V Raimondo, D Giuggioli, R Foti, M Caminiti, ... Journal of autoimmunity 125, 102744, 2021 | 118 | 2021 |
| A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection M Visentini, S Ludovisi, A Petrarca, F Pulvirenti, M Zaramella, M Monti, ... Autoimmunity reviews 10 (11), 714-719, 2011 | 92 | 2011 |
| Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: phase II clinical trial and systematic review M Visentini, C Tinelli, S Colantuono, M Monti, S Ludovisi, L Gragnani, ... Autoimmunity Reviews 14 (10), 889-896, 2015 | 76 | 2015 |
| Genome-wide association study of hepatitis C virus-and cryoglobulin-related vasculitis AL Zignego, GL Wojcik, P Cacoub, M Visentini, M Casato, A Mangia, ... Genes & Immunity 15 (7), 500-505, 2014 | 71 | 2014 |
| Efficacy of low-dose rituximab for mixed cryoglobulinemia M Visentini, M Granata, ML Veneziano, F Borghese, M Carlesimo, ... Clinical Immunology 125 (1), 30-33, 2007 | 65 | 2007 |
| Clonal B cells of HCV‐associated mixed cryoglobulinemia patients contain exhausted marginal zone‐like and CD21low cells overexpressing Stra13 M Visentini, M Cagliuso, V Conti, M Carbonari, M Cibati, G Siciliano, ... European journal of immunology 42 (6), 1468-1476, 2012 | 56 | 2012 |
| CD21−/low B cells associate with joint damage in rheumatoid arthritis patients K Thorarinsdottir, A Camponeschi, C Jonsson, K Granhagen Önnheim, ... Scandinavian journal of immunology 90 (2), e12792, 2019 | 49 | 2019 |
| Long-term outcome of WHIM syndrome in 18 patients: high risk of lung disease and HPV-related malignancies L Dotta, LD Notarangelo, D Moratto, R Kumar, F Porta, A Soresina, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1568-1577, 2019 | 48 | 2019 |
| Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration I Quinti, A Soresina, C Agostini, G Spadaro, A Matucci, I Sfika, H Martini, ... Journal of clinical immunology 28, 263-267, 2008 | 47 | 2008 |
| Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity M Visentini, V Conti, C Cristofoletti, C Lazzeri, R Marrapodi, G Russo, ... Autoimmunity reviews 12 (3), 430-435, 2013 | 41 | 2013 |
| Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection M Frigeni, C Besson, C Visco, H Fontaine, M Goldaniga, M Visentini, ... Leukemia 34 (5), 1462-1466, 2020 | 39 | 2020 |
| Long‐lasting persistence of large B‐cell clones in hepatitis C virus‐cured patients with complete response of mixed cryoglobulinaemia vasculitis M Visentini, M Del Padre, S Colantuono, B Yang, YA Minafò, S Antonini, ... Liver International 39 (4), 628-632, 2019 | 38 | 2019 |
| Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases F Ursini, P Ruscitti, V Raimondo, R De Angelis, F Cacciapaglia, E Pigatto, ... Annals of the Rheumatic Diseases 81 (3), 440-441, 2022 | 37 | 2022 |
| Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia M Del Padre, L Todi, M Mitrevski, R Marrapodi, S Colantuono, M Fiorilli, ... Blood, The Journal of the American Society of Hematology 130 (1), 35-38, 2017 | 37 | 2017 |
| CD21low B cells in systemic sclerosis: A possible marker of vascular complications R Marrapodi, C Pellicano, G Radicchio, G Leodori, S Colantuono, ... Clinical Immunology 213, 108364, 2020 | 32 | 2020 |
